eribulin mesylate
Generic: eribulin mesylate
Labeler: baxter healthcare companyDrug Facts
Product Profile
Brand Name
eribulin mesylate
Generic Name
eribulin mesylate
Labeler
baxter healthcare company
Dosage Form
INJECTION
Routes
Active Ingredients
eribulin mesylate .5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
10019-080
Product ID
10019-080_d075592c-a613-41ff-975a-e0855110fb75
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA217250
Listing Expiration
2027-12-31
Marketing Start
2024-10-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
10019080
Hyphenated Format
10019-080
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
eribulin mesylate (source: ndc)
Generic Name
eribulin mesylate (source: ndc)
Application Number
ANDA217250 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "d075592c-a613-41ff-975a-e0855110fb75", "openfda": {"upc": ["0310019080017"], "unii": ["AV9U0660CW"], "rxcui": ["1045456"], "spl_set_id": ["62690292-b1de-46f1-b6e8-012a725f8c63"], "manufacturer_name": ["Baxter Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "10019-080-01", "marketing_start_date": "20241201"}], "brand_name": "Eribulin Mesylate", "product_id": "10019-080_d075592c-a613-41ff-975a-e0855110fb75", "dosage_form": "INJECTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "10019-080", "generic_name": "Eribulin Mesylate", "labeler_name": "Baxter Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eribulin Mesylate", "active_ingredients": [{"name": "ERIBULIN MESYLATE", "strength": ".5 mg/mL"}], "application_number": "ANDA217250", "marketing_category": "ANDA", "marketing_start_date": "20241001", "listing_expiration_date": "20271231"}